Skip to content

Exercise Rehabilitation Trial in Huntington*s disease

Exercise Rehabilitation Trial in Huntington*s disease - ExeRT-HD

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON40355
Enrollment
8
Registered
2014-05-22
Start date
2014-06-01
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Huntington's disease

Interventions

The intervention is an exercise-based intervention with an aerobic component, three times per week for 12 weeks.

Sponsors

Cardiff University, Cardiff, UK
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) diagnosis of manifest HD, confirmed by genetic testing 2) above the age of 18 3) stable medication regime for four weeks prior to initiation of trial, and anticipated to be able to maintain a stable regime for the course of trial 4) enrolled in EHDN Registry study

Exclusion criteria

Exclusion criteria: 1) any physical or psychiatric condition that would prohibit the participant from completing the intervention or the full battery of assessments 2) inability to independently use the exercise bike 3) unable to understand or communicate in spoken English (UK sites only) 4) currently involved in any intervention trial or within four weeks of completing an intervention trial 5) current, regular participation in a structured exercise programme five times per week or more

Design outcomes

Primary

MeasureTime frame
The primary aim of this study is to assess feasibility of the exercise intervention in terms of adherence, safety and process. This will be achieved through the documentation of adherence and any adverse events, as well as any health-related changes such as falls, hospital admissions, or healthcare service use that occur during the intervention period. Duration of participation and dropout from the intervention will also be recorded. In order to assess benefits, a range of outcomes that are representative of participation, activities and body functions, as defined by the World Health Organisation Classification of Functioning, Disability and Health, will be obtained. These will include measures of physical fitness, cognitive ability, and motor function. Standard clinical measures of disease severity and function as well as health-related quality of life will also be obtained.

Secondary

MeasureTime frame
-

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)